6626 - 6650 of 9038 Results
Title
Year
- Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug Strategy2018RESTRICTEDTitle: Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug StrategyJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 11Start Page: 2542End Page: 2547Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00236Citation Count: 12
-
OPENTitle: Extracellular Vesicle‐Mediated Delivery of Constrained Peptides Disrupts the Pathogenic Interaction of LRRK2‐FADD in Parkinson's DiseaseJournal Name: Journal of Extracellular BiologyPublisher: WileyVol: 5Issue #: 2Start Page: e70116End Page: e70116Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jex2.70116Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jex2.70116Citation Count: 1
-
OPENTitle: Glycation of alpha-synuclein enhances aggregation and neuroinflammatory responsesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 307End Page: 307Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41531-025-01159-wBest OA location URL: https://www.nature.com/articles/s41531-025-01159-w.pdfCitation Count: 4
-
OPENTitle: Dopamine-related dissociation of cortical and subcortical brain activations in cognitively unimpaired Parkinson’s disease patients OFF and ON medicationsJournal Name: NeuropsychologiaPublisher: Elsevier BVVol: 119Issue #:Start Page: 24End Page: 33Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2018.07.024Best OA location URL: https://doi.org/10.1016/j.neuropsychologia.2018.07.024Citation Count: 19
-
OPENTitle: SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis studyJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 123Issue #: 10Start Page: e2517709123End Page: e2517709123Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.2517709123Best OA location URL: https://doi.org/10.1073/pnas.2517709123Citation Count: 0
- Randomized, Controlled Trial of Acupuncture for Fatigue in Parkinson's Disease2016RESTRICTEDTitle: Randomized, Controlled Trial of Acupuncture for Fatigue in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 7Start Page: 1027End Page: 1032Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26597Citation Count: 83
-
OPENTitle: Identification and In Vitro and In Vivo Characterization of KAC-50.1 as a Potential α-Synuclein PET RadioligandJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 15Issue #: 22Start Page: 4210End Page: 4219Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.4c00493Best OA location URL: https://doi.org/10.1021/acschemneuro.4c00493Citation Count: 7
-
OPENTitle: Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System AtrophyJournal Name: The American Journal of PathologyPublisher: Elsevier BVVol: 178Issue #: 4Start Page: 1509End Page: 1516Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ajpath.2011.01.006Best OA location URL: http://ajp.amjpathol.org/article/S0002944011000575/pdfCitation Count: 123
-
RESTRICTEDTitle: Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathologyJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 131Issue #: 3Start Page: 393End Page: 409Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-015-1526-9Best OA location URL: http://doi.org/10.1007/s00401-015-1526-9Citation Count: 182
-
OPENTitle: Increased Phospho‐AKT in Blood Cells from LRRK2 G2019S Mutation CarriersJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: 5Start Page: 888End Page: 894Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.26469Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26469Citation Count: 2
- Deep Brain Stimulation associated gliosis: A post-mortem study2018RESTRICTEDTitle: Deep Brain Stimulation associated gliosis: A post-mortem studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 54Issue #:Start Page: 51End Page: 55Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.04.009Citation Count: 36
-
OPENTitle: Joint pattern analysis applied to PET DAT and VMAT2 imaging reveals new insights into Parkinson's disease induced presynaptic alterationsJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 23Issue #:Start Page: 101856End Page: 101856Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2019.101856Best OA location URL: https://doi.org/10.1016/j.nicl.2019.101856Citation Count: 29
- Effects of Verbal Cueing on Respiratory-Swallow Patterning, Lung Volume Initiation, and Swallow Apnea Duration in Parkinson’s Disease2019RESTRICTEDTitle: Effects of Verbal Cueing on Respiratory-Swallow Patterning, Lung Volume Initiation, and Swallow Apnea Duration in Parkinson’s DiseaseJournal Name: DysphagiaPublisher: Springer Science and Business Media LLCVol: 35Issue #: 3Start Page: 460End Page: 470Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00455-019-10050-9Citation Count: 31
-
OPENTitle: P2RX7, an adaptive immune response gene, is associated with Parkinson's disease risk and age at onsetJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 14Issue #: 8Start Page: 1575End Page: 1583Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x241296015Best OA location URL: https://doi.org/10.1177/1877718x241296015Citation Count: 1
-
OPENTitle: Lysosome and Inflammatory Defects in GBA1‐Mutant Astrocytes Are Normalized by LRRK2 InhibitionJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 760End Page: 773Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27994Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8167931Citation Count: 108
- GBA variation and susceptibility to multiple system atrophy2020RESTRICTEDTitle: GBA variation and susceptibility to multiple system atrophyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 64End Page: 69Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.007Citation Count: 26
-
OPENTitle: Hemispheric lateralization of dopamine transporter binding in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 141Issue #:Start Page: 108076End Page: 108076Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108076Best OA location URL: https://doi.org/10.1016/j.parkreldis.2025.108076Citation Count: 0
-
OPENTitle: Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 8Start Page: 748End Page: 759Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30140-1Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/113416685/MainText_Politis_RevisedManuscript_Clean.pdfCitation Count: 98
-
OPENTitle: NeuroBooster Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse PopulationsJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 11Start Page: 2039End Page: 2048Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29902Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29902Citation Count: 38
- Pyridine-Fused 2-Pyridones via Povarov and A3 Reactions: Rapid Generation of Highly Functionalized Tricyclic Heterocycles Capable of Amyloid Fibril Binding2019RESTRICTEDTitle: Pyridine-Fused 2-Pyridones via Povarov and A3 Reactions: Rapid Generation of Highly Functionalized Tricyclic Heterocycles Capable of Amyloid Fibril BindingJournal Name: The Journal of Organic ChemistryPublisher: American Chemical Society (ACS)Vol: 84Issue #: 7Start Page: 3887End Page: 3903Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.joc.8b03015Citation Count: 22
-
OPENTitle: Pooled analysis of iron-related genes in Parkinson's disease: Association with transferrinJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 62Issue #:Start Page: 172End Page: 178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2013.09.019Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0969996113002659Citation Count: 87
-
OPENTitle: Radiolabeled Aminopyrazoles as Novel Isoform Selective Probes for pJNK3 QuantificationJournal Name: ACS Medicinal Chemistry LettersPublisher: American Chemical Society (ACS)Vol: 13Issue #: 10Start Page: 1606End Page: 1614Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsmedchemlett.2c00278Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9575163Citation Count: 4
- Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease2020RESTRICTEDTitle: Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's diseaseJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 871Issue #:Start Page: 172914End Page: 172914Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejphar.2020.172914Citation Count: 21
-
OPENTitle: Prevalence and Risk Factors for Double Vision in Parkinson DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 5Start Page: 709End Page: 712Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13220Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13220Citation Count: 12
- A Phase 2A Trial of the Novel mGluR5‐Negative Allosteric Modulator Dipraglurant for Levodopa‐Induced Dyskinesia in Parkinson's Disease2016RESTRICTEDTitle: A Phase 2A Trial of the Novel mGluR5‐Negative Allosteric Modulator Dipraglurant for Levodopa‐Induced Dyskinesia in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 9Start Page: 1373End Page: 1380Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26659Citation Count: 140